Abstract No. 1 ▪ ABSTRACT OF THE YEAR Catheter-Directed Organ-Targeting Immune Augmentation Using a Nanoparticle-Based Therapeutic in a Rat de Novo HCC Model
To evaluate whether selective intra-arterial administration (IA) of PD-L1-conjugated nanoparticles (Antigen Release Agent and Checkpoint Inhibitor, ARAC) with tumor-homing capabilities can augment the tumor immune environment in a rat HCC model.
vigna
0
0
To evaluate whether selective intra-arterial administration (IA) of PD-L1-conjugated nanoparticles (Antigen Release Agent and Checkpoint Inhibitor, ARAC) with tumor-homing capabilities can augment the tumor immune environment in a rat HCC model.
